History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
- PMID: 20228997
- DOI: 10.1007/s10552-010-9530-9
History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
Abstract
Objective: The association between diabetes mellitus and the risk of prostate cancer has been tested in previous prospective cohort studies in western populations. However, no evidence from cohort studies is available for Asian populations, whose lifestyle is very different from that of westerners.
Methods: The authors examined the relationship between diabetes mellitus and the risk of prostate cancer in the Ohsaki cohort followed from 1995 to 2003, in which 230 new cases of prostate cancer were identified among 22,458 Japanese men. Baseline information including diabetes mellitus status was collected using a self-administered questionnaire. The Cox proportional hazards regression model was used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).
Results: Although a history of diabetes mellitus was not associated with the risk of total prostate cancer in this population, after stratification based on the clinical stage of prostate cancer, patients with diabetes mellitus showed a higher risk of advanced prostate cancer with a multivariate adjusted HR = 1.89 (95% CI: 1.02-3.50). The relationship remained robust when we excluded from the analysis cases arising in the first 2 years.
Conclusion: This population-based prospective cohort study indicates that a history of diabetes mellitus is associated with an increased incidence of advanced prostate cancer.
Similar articles
-
Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.Cancer Causes Control. 2007 Aug;18(6):603-12. doi: 10.1007/s10552-007-9002-z. Epub 2007 Mar 31. Cancer Causes Control. 2007. PMID: 17401636
-
History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).Cancer Causes Control. 2005 Sep;16(7):789-97. doi: 10.1007/s10552-005-3301-z. Cancer Causes Control. 2005. PMID: 16132789
-
Diabetes and risk of prostate cancer in a prospective cohort of US men.Am J Epidemiol. 2005 Jan 15;161(2):147-52. doi: 10.1093/aje/kwh334. Am J Epidemiol. 2005. PMID: 15632264
-
Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.Diabetes Metab Res Rev. 2015 May;31(4):336-43. doi: 10.1002/dmrr.2582. Epub 2014 Sep 14. Diabetes Metab Res Rev. 2015. PMID: 25066306 Review.
-
Periodontal disease and the risk of prostate cancer: a meta-analysis of cohort studies.Int Braz J Urol. 2021 Nov-Dec;47(6):1120-1130. doi: 10.1590/S1677-5538.IBJU.2020.0333. Int Braz J Urol. 2021. PMID: 33650836 Free PMC article. Review.
Cited by
-
Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008.Medicine (Baltimore). 2017 Dec;96(51):e9427. doi: 10.1097/MD.0000000000009427. Medicine (Baltimore). 2017. PMID: 29390570 Free PMC article.
-
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with prostate cancer.ESMO Open. 2022 Aug;7(4):100518. doi: 10.1016/j.esmoop.2022.100518. Epub 2022 Jul 4. ESMO Open. 2022. PMID: 35797737 Free PMC article.
-
Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study.BMC Cancer. 2020 Jun 15;20(1):551. doi: 10.1186/s12885-020-07036-4. BMC Cancer. 2020. PMID: 32539807 Free PMC article.
-
Triglyceride-glucose index is a predictor of the risk of prostate cancer: a retrospective study based on a transprostatic aspiration biopsy population.Front Endocrinol (Lausanne). 2024 Jan 8;14:1280221. doi: 10.3389/fendo.2023.1280221. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38260162 Free PMC article.
-
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products.Molecules. 2021 Apr 10;26(8):2179. doi: 10.3390/molecules26082179. Molecules. 2021. PMID: 33920079 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical